EVENT |  I Jornada de Publicitat dels Medicaments de Catalunya  

November 28, 2024

The first-ever conference on medicinal products promotion in Catalonia brought together industry leaders to discuss the latest updates, challenges, and opportunities in ensuring ethical and compliant pharmaceutical marketing practices.

Key Takeaways:

  • “The modification of the Royal Decree on promotion is in the Ministry of Health’s plans for 2025.” – Javier García del Pozo
  • Increasing training and capacity-building in the pharmaceutical industry is crucial for ensuring compliance with promotion legislation.
  • Catalonia hosts 136 pharmaceutical companies, accounting for 43% of Spain’s pharmaceutical industry—a significant contribution to the sector.

Seeking a regulatory ally to guarantee your company’s marketing materials comply with Spanish regulations?

Our services include:

  • Comprehensive regulatory and medical material review
  • Ensuring digital presence and website compliance
  • Direct liaison with regulatory authorities
  • Bespoke SOP development
  • Tailored training programs
  • Management of digital tools for clients’ materials
  • Regulatory intelligence for marketing regulations

 

Achieve top-tier compliance for Spanish Promotional Material Compliance with Asphalion!

Contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

NEWS | Asphalion Highlights summary from the Clinical Data Publication (Policy 0070) Step 2 EMA Webinar

The European Medicines Agency (EMA) has presented today on an insightful webinar its plans on the proposed expansion of activities (Step 2) related to Policy 0070 from April 2025 and the handling of legacy procedures. It has also provided guidance for applicants and industry stakeholders, including small and medium-sized enterprises intending to submit clinical data for publication.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting